AKT1 and hepatoblastoma: In intrahepatic cholangiocarcinoma (myr-AKT/YAPS127A) a stronger and in hepatoblastoma (YAPS127A/β-catenin) a less prominent CK19 positivity in tumor cells was observed [32, 33].